Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
34.16
+0.86 (2.58%)
At close: May 29, 2026, 4:00 PM EDT
34.96
+0.80 (2.35%)
After-hours: May 29, 2026, 7:26 PM EDT
Edgewise Therapeutics Employees
Edgewise Therapeutics had 154 employees as of March 31, 2026. The number of employees increased by 8 or 5.48% since the number was last reported on December 31, 2025.
Employees
154
Change
8
Growth
5.48%
Revenue / Employee
n/a
Profits / Employee
-$1,142,922
Market Cap
3.68B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 154 | 8 | 5.48% |
| Dec 31, 2025 | 146 | 36 | 32.73% |
| Dec 31, 2024 | 110 | 22 | 25.00% |
| Dec 31, 2023 | 88 | 29 | 49.15% |
| Dec 31, 2022 | 59 | 28 | 90.32% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Beam Therapeutics | 522 |
| Denali Therapeutics | 507 |
| Catalyst Pharmaceuticals | 182 |
| Erasca | 103 |
EWTX News
- 10 days ago - Edgewise Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2026 - PRNewsWire
- 23 days ago - Edgewise Therapeutics Quarterly report: Q1 2026 - Filings
- 23 days ago - Edgewise Therapeutics Earnings release: Q1 2026 - Filings
- 23 days ago - Edgewise Therapeutics reports Q1 EPS (46c), consensus (49c) - TheFly
- 23 days ago - Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications - PRNewsWire
- 23 days ago - Edgewise Therapeutics price target raised to $52 from $46 at Truist - TheFly
- 25 days ago - Edgewise Therapeutics rises 18.1% - TheFly